The class of medications called glucagon-like peptide-1 receptor agonists (GLP-1RAs) was first authorized in the early 2000s and includes semaglutide, which gained Food and Drug Administration (FDA) approval in 2017 for patients with Type 2 diabetes
You can read the full article at Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial This study investigated the effects of tirzepatide, a medication used to treat type 2 diabetes, on the bodys physiological mechanisms
Its particularly helpful for individuals who feel their energy drops more quickly on reduced calorie intake, or those who want to optimize mitochondrial function during active fat loss
According to the official label approved by the U.S
Mounjaro was approved by the FDA in May 2022 for type 2 diabetes management in adults as a way to improve blood sugar when combined with diet and exercise